Using UNC's expertise to fight emerging diseases
Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that.
(UNC.edu)
Related: Campus Connections
Instagram account uncquirks serves as digital scrapbook of on-campus lifeThe University of North Carolina is full of personality — possums in trash cans, unicycles made from Jordans and Squidward-shaped snowmen in the winter time...
Thu Jul 17, 2025UNC students face flood damage from Chantal on and off campus, may be eligible for University aid
On Sunday, July 6, Chapel Hill and surrounding areas faced heavy rain and flooding from Tropical Storm Chantal, which damaged some University of North Carolina...
Tue Jul 15, 2025
Parts of Chapel Hill return to business. Others remain in limbo after Chantal
Remnants of Tropical Storm Chantal left many stores and restaurants in Chapel Hill submerged in 5 feet of water. Eastgate Crossing and Mariakakis Plaza were...
Mon Jul 14, 2025
Excellence Unveiled: Karsen Kitchen
In the sixth installment of Excellence Unveiled, listen to Karsen Kitchen, class of 2025, discuss her 20-minute journey aboard a Blue Origin rocket and her...
Sat Jul 12, 2025